Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 16/20 | 0.65 |
| ▸ | CCNT1 | O60563 | 12/20 | 0.65 |
| ▸ | CDK2 | P24941 | 9/20 | 0.65 |
| ▸ | GSK3A | P49840 | 4/20 | 0.65 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.65 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.65 |
| ▸ | CDK1 | P06493 | 3/20 | 0.65 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.65 |
| ▸ | ABL2 | P42684 | 3/20 | 0.65 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.65 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.65 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.65 |
| ▸ | CDK4 | P11802 | 2/20 | 0.65 |
| ▸ | CCND1 | P24385 | 2/20 | 0.65 |
| ▸ | CDK7 | P50613 | 2/20 | 0.65 |
| ▸ | CCNH | P51946 | 2/20 | 0.65 |
| ▸ | MNAT1 | P51948 | 2/20 | 0.65 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.57 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.57 |
| ▸ | GSK3B | P49841 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2982598 | 0.90 | CDK9 (0.52) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL3005997 | 0.87 | CDK9 (0.70) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL3003624 | 0.87 | CDK9 (0.49) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL3010489 | 0.84 | CDK9 (0.47) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL4429850 | 0.82 | CDK9 (0.74) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL3005199 | 0.81 | CDK9 (0.61) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL2462384 | 0.81 | CDK9 (0.84) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL29942481 | 0.81 | CDK9 (0.84) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL4430368 | 0.79 | CDK9 (1.00) | CDK9CCNT1CDK2GSK3ACDK5 | |
| SCHEMBL29486339 | 0.79 | CDK9 (1.00) | CDK9CCNT1CDK2GSK3ACDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436007-B2 | Inhibitors of protein kinases | INGENIUM PHARMACEUTICALS GMBH (DE) | 2013-05-07 | — | — | US | claimed |
| US-20100184789-A1 | INHIBITORS OF PROTEIN KINASES | ASTRAZENECA AB (SE) | 2010-07-22 | — | — | US | claimed |
| EP-2137163-B1 | INHIBITORS OF PROTEIN KINASES | ASTRAZENECA AB (SE) | 2015-03-18 | — | — | EP | disclosed |
| US-8436007-B2 | Inhibitors of protein kinases | INGENIUM PHARMACEUTICALS GMBH (DE) | 2013-05-07 | — | — | US | disclosed |
| US-8436007-B2 | Inhibitors of protein kinases | INGENIUM PHARMACEUTICALS GMBH (DE) | 2013-05-07 | — | — | US | disclosed |
| US-8436007-B2 | Inhibitors of protein kinases | INGENIUM PHARMACEUTICALS GMBH (DE) | 2013-05-07 | — | — | US | disclosed |
| US-20100184789-A1 | INHIBITORS OF PROTEIN KINASES | ASTRAZENECA AB (SE) | 2010-07-22 | — | — | US | disclosed |
| US-20100184789-A1 | INHIBITORS OF PROTEIN KINASES | ASTRAZENECA AB (SE) | 2010-07-22 | — | — | US | disclosed |
| US-20100184789-A1 | INHIBITORS OF PROTEIN KINASES | ASTRAZENECA AB (SE) | 2010-07-22 | — | — | US | disclosed |
| WO-2008129070-A1 | INHIBITORS OF PROTEIN KINASES | INGENIUM PHARMACEUTICALS GMBH (DE) | 2008-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184789-A1 | INHIBITORS OF PROTEIN KINASES | CDK1, CDK2, CDK5 | CDK9 11/4885CCNT1 48/4885CDK2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.